ID
44584
Description
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072
Keywords
Versions (3)
- 9/30/15 9/30/15 -
- 10/27/15 10/27/15 -
- 9/27/21 9/27/21 -
Uploaded on
September 27, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CLL History BO17072 NCT00090051
History of Chronic lymphocytic leukemia NCT0090051
- StudyEvent: ODM
Description
after al least 5 minutes rest
Description
systolic
Data type
integer
Measurement units
- mmHg
Alias
- UMLS CUI-1
- C0871470
Description
diastolic
Data type
integer
Measurement units
- mmHg
Alias
- UMLS CUI-1
- C0428883
Description
Pulse rate
Data type
integer
Measurement units
- bpm
Alias
- UMLS CUI-1
- C0232117
Description
"B" symptoms
Description
General physical examination
Description
ECG
Alias
- UMLS CUI-1
- C1623258
Description
Date ECG performed
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C2826846
Description
Abnormalities in the ECG
Data type
boolean
Alias
- UMLS CUI [1]
- C0236140
Description
Specification of abnormalities
Data type
text
Alias
- UMLS CUI [1]
- C0205161
Similar models
History of Chronic lymphocytic leukemia NCT0090051
- StudyEvent: ODM